1	Therapeutic	Therapeutic	B-NP	JJ	O	2	NMOD	-1
2	targeting	targeting	I-NP	NN	O	10	NMOD	16	targeting
3	of	of	B-PP	IN	O	2	NMOD	-1
4	the	the	B-NP	DT	O	6	NMOD	-1
5	survivin	survivin	I-NP	NN	O	6	NMOD	-1
6	pathway	pathway	I-NP	NN	O	3	PMOD	0
7	in	in	B-PP	IN	O	2	NMOD	-1
8	cancer	cancer	B-NP	NN	O	7	PMOD	-1
9	:	:	O	:	O	2	P	-1
10	initiation	initiation	B-NP	NN	O	15	NMOD	0
11	of	of	B-PP	IN	O	10	NMOD	-1
12	mitochondrial	mitochondrial	B-NP	JJ	O	13	NMOD	-1
13	apoptosis	apoptosis	I-NP	NN	O	11	PMOD	0
14	and	and	I-NP	CC	O	15	NMOD	-1
15	suppression	suppression	I-NP	NN	O	0	ROOT	18	suppression
16	of	of	B-PP	IN	O	15	NMOD	-1
17	tumor-associated	tumor-associated	B-NP	JJ	O	18	NMOD	-1
18	angiogenesis	angiogenesis	I-NP	NN	O	16	PMOD	3	angiogenesis
19	.	.	O	.	O	15	P	-1

1	PURPOSE	PURPOSE	B-NP	NN	O	4	NMOD	-1
2	:	:	O	:	O	1	P	-1
3	Molecular	Molecular	B-NP	JJ	O	4	NMOD	-1
4	antagonists	antagonist	I-NP	NNS	O	12	SUB	-1
5	of	of	B-PP	IN	O	4	NMOD	-1
6	the	the	B-NP	DT	O	7	NMOD	-1
7	inhibitor	inhibitor	I-NP	NN	O	5	PMOD	0
8	of	of	B-PP	IN	O	7	NMOD	-1
9	apoptosis	apoptosis	B-NP	NN	O	11	NMOD	0
10	protein	protein	I-NP	NN	O	11	NMOD	-1
11	survivin	survivin	I-NP	NN	O	8	PMOD	-1
12	have	have	B-VP	VBP	O	0	ROOT	-1
13	shown	show	I-VP	VBN	O	12	VC	-1
14	promise	promise	B-NP	NN	O	13	OBJ	-1
15	as	as	B-PP	IN	O	13	VMOD	-1
16	novel	novel	B-NP	JJ	O	18	NMOD	-1
17	anticancer	anticancer	I-NP	JJ	O	18	NMOD	-1
18	strategies	strategy	I-NP	NNS	O	15	PMOD	-1
19	for	for	B-PP	IN	O	18	NMOD	-1
20	triggering	trigger	B-VP	VBG	O	19	PMOD	17	triggering
21	tumor	tumor	B-NP	NN	O	23	NMOD	-1
22	cell	cell	I-NP	NN	O	23	NMOD	-1
23	apoptosis	apoptosis	I-NP	NN	O	20	OBJ	5	apoptosis
24	,	,	O	,	O	18	P	-1
25	dysregulating	dysregulate	B-VP	VBG	O	18	NMOD	-1
26	mitotic	mitotic	B-NP	JJ	O	27	NMOD	-1
27	progression	progression	I-NP	NN	O	25	OBJ	0
28	,	,	O	,	O	12	P	-1
29	and	and	O	CC	O	12	VMOD	-1
30	inhibiting	inhibit	B-VP	VBG	O	12	VMOD	18	inhibiting
31	tumor	tumor	B-NP	NN	O	32	NMOD	-1
32	growth	growth	I-NP	NN	O	30	OBJ	4	growth
33	in	in	B-PP	IN	O	32	NMOD	-1
34	preclinical	preclinical	B-NP	JJ	O	35	NMOD	-1
35	models	model	I-NP	NNS	O	33	PMOD	-1
36	.	.	O	.	O	12	P	-1

1	However	However	B-ADVP	RB	O	23	VMOD	-1
2	,	,	O	,	O	23	P	-1
3	how	how	B-ADVP	WRB	O	23	VMOD	-1
4	survivin	survivin	B-NP	NN	O	5	NMOD	-1
5	couples	couple	I-NP	NNS	O	11	SUB	-1
6	to	to	B-PP	TO	O	5	NMOD	-1
7	the	the	B-NP	DT	O	10	NMOD	-1
8	cell	cell	I-NP	NN	O	10	NMOD	-1
9	death	death	I-NP	NN	O	10	NMOD	5	death
10	machinery	machinery	I-NP	NN	O	6	PMOD	-1
11	has	have	B-VP	VBZ	O	3	SBAR	-1
12	remained	remain	I-VP	VBN	O	11	VC	-1
13	elusive	elusive	B-ADJP	JJ	O	12	PRD	-1
14	,	,	O	,	O	23	P	-1
15	and	and	O	CC	O	19	NMOD	-1
16	the	the	B-NP	DT	O	19	NMOD	-1
17	relevant	relevant	I-NP	JJ	O	19	NMOD	-1
18	cellular	cellular	I-NP	JJ	O	19	NMOD	-1
19	targets	target	I-NP	NNS	O	23	SUB	0
20	of	of	B-PP	IN	O	19	NMOD	-1
21	survivin	survivin	B-NP	NN	O	22	NMOD	-1
22	antagonists	antagonist	I-NP	NNS	O	20	PMOD	-1
23	have	have	B-VP	VBP	O	0	ROOT	-1
24	not	not	I-VP	RB	O	23	VMOD	-1
25	been	be	I-VP	VBN	O	23	VC	-1
26	completely	completely	B-ADJP	RB	O	27	VMOD	-1
27	elucidated	elucidate	I-ADJP	VBN	O	25	VC	-1
28	.	.	O	.	O	23	P	-1

1	Experimental	Experimental	B-NP	NNP	O	2	NMOD	-1
2	Design	Design	I-NP	NNP	O	11	NMOD	-1
3	:	:	O	:	O	2	P	-1
4	Human	Human	B-NP	JJ	B-cell_type	6	NMOD	-1
5	umbilical	umbilical	I-NP	JJ	I-cell_type	6	NMOD	-1
6	vein	vein	I-NP	NN	I-cell_type	2	NMOD	-1
7	and	and	O	CC	I-cell_type	11	NMOD	-1
8	dermal	dermal	B-NP	JJ	I-cell_type	11	NMOD	-1
9	microvascular	microvascular	I-NP	JJ	I-cell_type	11	NMOD	-1
10	endothelial	endothelial	I-NP	JJ	I-cell_type	11	NMOD	-1
11	cells	cell	I-NP	NNS	I-cell_type	12	SUB	-1
12	were	be	B-VP	VBD	O	0	ROOT	-1
13	infected	infect	I-VP	VBN	O	12	VC	19	infected
14	with	with	B-PP	IN	O	13	VMOD	-1
15	replication-deficient	replication-deficient	B-NP	JJ	O	16	NMOD	-1
16	adenoviruses	adenovirus	I-NP	NNS	O	14	PMOD	-1
17	encoding	encode	B-VP	VBG	O	16	NMOD	-1
18	survivin	survivin	B-NP	NN	O	25	NMOD	-1
19	(	(	O	(	O	21	DEP	-1
20	pAd-Survivin	pAd-Survivin	B-NP	NN	B-protein	21	DEP	-1
21	)	)	O	)	O	18	NMOD	-1
22	,	,	O	,	O	25	P	-1
23	green	green	B-NP	JJ	B-protein	25	NMOD	-1
24	fluorescent	fluorescent	I-NP	JJ	I-protein	25	NMOD	-1
25	protein	protein	I-NP	NN	I-protein	34	NMOD	-1
26	(	(	O	(	O	28	DEP	-1
27	pAd-GFP	pAd-GFP	B-NP	NN	B-protein	28	DEP	-1
28	)	)	O	)	O	25	NMOD	-1
29	,	,	O	,	O	34	P	-1
30	or	or	O	CC	O	34	NMOD	-1
31	a	a	B-NP	DT	O	34	NMOD	-1
32	phosphorylation-defective	phosphorylation-defective	I-NP	JJ	O	34	NMOD	-1
33	survivin	survivin	I-NP	NN	O	34	NMOD	-1
34	Thr	Thr	I-NP	NN	O	17	OBJ	-1
35	(	(	O	(	O	37	DEP	-1
36	34	34	B-NP	CD	O	37	DEP	-1
37	)	)	O	)	O	34	NMOD	-1
38	--	--	O	:	O	46	P	-1
39	>	>	O	SYM	O	46	NMOD	-1
40	Ala	Ala	B-NP	NN	B-protein	46	NMOD	-1
41	(	(	O	(	O	43	DEP	-1
42	pAd-T34A	pAd-T34A	B-NP	NN	O	43	DEP	-1
43	)	)	O	)	O	40	NMOD	-1
44	dominant	dominant	B-NP	JJ	O	46	NMOD	-1
45	negative	negative	I-NP	JJ	O	46	NMOD	0
46	mutant	mutant	I-NP	NN	O	12	VMOD	-1
47	.	.	O	.	O	12	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	effect	effect	I-NP	NN	O	8	SUB	16	effect
3	of	of	B-PP	IN	O	2	NMOD	-1
4	wild-type	wild-type	B-NP	JJ	O	7	NMOD	-1
5	or	or	I-NP	CC	O	7	NMOD	-1
6	mutant	mutant	I-NP	JJ	O	7	NMOD	-1
7	survivin	survivin	I-NP	NN	O	3	PMOD	-1
8	was	be	B-VP	VBD	O	0	ROOT	-1
9	investigated	investigate	I-VP	VBN	O	8	VC	-1
10	on	on	B-PP	IN	O	9	VMOD	-1
11	capillary	capillary	B-NP	JJ	O	13	NMOD	-1
12	network	network	I-NP	NN	O	13	NMOD	-1
13	stability	stability	I-NP	NN	O	17	NMOD	-1
14	,	,	O	,	O	17	P	-1
15	endothelial	endothelial	B-NP	JJ	O	17	NMOD	-1
16	cell	cell	I-NP	NN	O	17	NMOD	-1
17	viability	viability	I-NP	NN	O	10	PMOD	-1
18	,	,	O	,	O	17	P	-1
19	and	and	O	CC	O	18	PMOD	-1
20	caspase	caspase	B-NP	NN	B-protein	21	NMOD	-1
21	activation	activation	I-NP	NN	O	19	PMOD	17	activation
22	in	in	B-ADVP	FW	O	21	NMOD	-1
23	vitro	vitro	I-ADVP	FW	O	22	AMOD	-1
24	and	and	O	CC	O	21	NMOD	-1
25	on	on	B-PP	IN	O	24	PMOD	-1
26	kinetics	kinetic	B-NP	NNS	O	25	PMOD	-1
27	of	of	B-PP	IN	O	26	NMOD	-1
28	tumor	tumor	B-NP	NN	O	29	NMOD	-1
29	growth	growth	I-NP	NN	O	31	NMOD	4	growth
30	and	and	O	CC	O	31	NMOD	-1
31	development	development	B-NP	NN	O	27	PMOD	0
32	of	of	B-PP	IN	O	31	NMOD	-1
33	angiogenesis	angiogenesis	B-NP	NN	O	32	PMOD	3	angiogenesis
34	in	in	B-PP	IN	O	25	PMOD	-1
35	a	a	B-NP	DT	O	39	NMOD	-1
36	breast	breast	I-NP	NN	O	39	NMOD	-1
37	cancer	cancer	I-NP	NN	O	39	NMOD	-1
38	xenograft	xenograft	I-NP	NN	O	39	NMOD	-1
39	model	model	I-NP	NN	O	34	PMOD	-1
40	in	in	B-ADVP	FW	O	39	NMOD	-1
41	vivo	vivo	I-ADVP	FW	O	40	AMOD	-1
42	.	.	O	.	O	8	P	-1

1	The	The	B-NP	DT	O	4	NMOD	-1
2	cell	cell	I-NP	NN	O	4	NMOD	-1
3	death	death	I-NP	NN	O	4	NMOD	5	death
4	pathway	pathway	I-NP	NN	O	9	SUB	0
5	initiated	initiate	B-VP	VBN	O	4	NMOD	17	initiated
6	by	by	B-PP	IN	O	5	VMOD	-1
7	survivin	survivin	B-NP	NN	O	8	NMOD	-1
8	targeting	targeting	I-NP	NN	O	6	PMOD	19	targeting
9	was	be	B-VP	VBD	O	0	ROOT	-1
10	mapped	map	I-VP	VBN	O	9	VC	-1
11	with	with	B-PP	IN	O	10	VMOD	-1
12	respect	respect	B-NP	NN	O	11	PMOD	-1
13	to	to	B-PP	TO	O	12	NMOD	-1
14	cytochrome	cytochrome	B-NP	NN	B-protein	16	NMOD	-1
15	c	c	I-NP	NN	I-protein	16	NMOD	-1
16	release	release	I-NP	NN	O	13	PMOD	14	release
17	,	,	O	,	O	26	P	-1
18	changes	change	B-NP	NNS	O	26	NMOD	0
19	in	in	B-PP	IN	O	18	NMOD	-1
20	mitochondrial	mitochondrial	B-NP	JJ	O	22	NMOD	-1
21	transmembrane	transmembrane	I-NP	JJ	O	22	NMOD	-1
22	potential	potential	I-NP	NN	O	19	PMOD	0
23	,	,	O	,	O	26	P	-1
24	and	and	O	CC	O	26	NMOD	-1
25	apoptosome	apoptosome	B-NP	NN	O	26	NMOD	-1
26	requirements	requirement	I-NP	NNS	O	11	PMOD	-1
27	using	use	B-VP	VBG	O	26	NMOD	-1
28	mouse	mouse	B-NP	NN	B-cell_type	30	NMOD	-1
29	embryonic	embryonic	I-NP	JJ	I-cell_type	30	NMOD	-1
30	fibroblasts	fibroblast	I-NP	NNS	I-cell_type	27	OBJ	-1
31	deficient	deficient	B-ADJP	JJ	O	30	NMOD	9	deficient
32	in	in	B-PP	IN	O	31	AMOD	-1
33	Apaf-1	Apaf-1	B-NP	NN	B-protein	35	NMOD	-1
34	or	or	I-NP	CC	O	35	NMOD	-1
35	caspase-9	caspase-9	I-NP	NN	B-protein	32	PMOD	-1
36	.	.	O	.	O	9	P	-1

1	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	-1
3	Adenoviral	Adenoviral	B-NP	JJ	O	4	NMOD	-1
4	transduction	transduction	I-NP	NN	O	10	SUB	19	transduction
5	of	of	B-PP	IN	O	4	NMOD	-1
6	endothelial	endothelial	B-NP	JJ	B-cell_type	7	NMOD	-1
7	cells	cell	I-NP	NNS	I-cell_type	5	PMOD	-1
8	with	with	B-PP	IN	O	4	NMOD	-1
9	pAd-Survivin	pAd-Survivin	B-NP	NN	O	8	PMOD	-1
10	inhibited	inhibit	B-VP	VBD	O	1	NMOD	0
11	growth	growth	B-NP	NN	B-protein	13	NMOD	0
12	factor	factor	I-NP	NN	I-protein	13	NMOD	-1
13	deprivation-	deprivation-	I-NP	NN	O	16	NMOD	-1
14	or	or	O	CC	O	16	NMOD	-1
15	ceramide-induced	ceramide-induced	B-NP	JJ	O	16	NMOD	-1
16	apoptosis	apoptosis	I-NP	NN	O	10	OBJ	0
17	,	,	O	,	O	10	P	-1
18	reduced	reduce	B-VP	VBD	O	10	VMOD	18	reduced
19	caspase-3	caspase-3	B-NP	NN	B-protein	22	NMOD	-1
20	and	and	O	CC	I-protein	22	NMOD	-1
21	-7	-7	B-NP	CD	I-protein	22	NMOD	-1
22	generation	generation	I-NP	NN	O	18	OBJ	9	generation
23	,	,	O	,	O	10	P	-1
24	and	and	O	CC	O	10	VMOD	-1
25	stabilized	stabilize	B-VP	VBD	O	10	VMOD	-1
26	three-dimensional	three-dimensional	B-NP	JJ	O	28	NMOD	-1
27	capillary	capillary	I-NP	JJ	O	28	NMOD	-1
28	networks	network	I-NP	NNS	O	25	OBJ	-1
29	in	in	B-ADVP	FW	O	10	VMOD	-1
30	vitro	vitro	I-ADVP	FW	O	29	AMOD	-1
31	.	.	O	.	O	1	P	-1

1	Conversely	Conversely	B-ADVP	RB	O	6	VMOD	-1
2	,	,	O	,	O	6	P	-1
3	expression	expression	B-NP	NN	O	6	SUB	9	expression
4	of	of	B-PP	IN	O	3	NMOD	-1
5	pAd-T34A	pAd-T34A	B-NP	NN	B-protein	4	PMOD	-1
6	caused	cause	B-VP	VBD	O	0	ROOT	17	caused
7	apoptosis	apoptosis	B-NP	NN	O	6	OBJ	5	apoptosis
8	in	in	B-PP	IN	O	6	VMOD	-1
9	umbilical	umbilical	B-NP	JJ	O	10	NMOD	-1
10	vein	vein	I-NP	NN	O	15	NMOD	-1
11	and	and	O	CC	O	15	NMOD	-1
12	dermal	dermal	B-NP	JJ	O	15	NMOD	-1
13	microvascular	microvascular	I-NP	JJ	O	15	NMOD	-1
14	endothelial	endothelial	I-NP	JJ	B-cell_type	15	NMOD	-1
15	cells	cell	I-NP	NNS	I-cell_type	8	PMOD	-1
16	and	and	O	CC	O	6	VMOD	-1
17	resulted	result	B-VP	VBD	O	6	VMOD	17	resulted
18	in	in	B-PP	IN	O	17	VMOD	-1
19	caspase-3	caspase-3	B-NP	NN	B-protein	20	NMOD	-1
20	activity	activity	I-NP	NN	O	18	PMOD	0
21	.	.	O	.	O	6	P	-1

1	Cell	Cell	B-NP	NN	O	2	NMOD	-1
2	death	death	I-NP	NN	O	7	SUB	5	death
3	induced	induce	B-VP	VBN	O	2	NMOD	17	induced
4	by	by	B-PP	IN	O	3	VMOD	-1
5	survivin	survivin	B-NP	NN	O	6	NMOD	-1
6	targeting	targeting	I-NP	NN	O	4	PMOD	19	targeting
7	exhibited	exhibit	B-VP	VBD	O	0	ROOT	0
8	the	the	B-NP	DT	O	9	NMOD	-1
9	hallmarks	hallmark	I-NP	NNS	O	7	OBJ	-1
10	of	of	B-PP	IN	O	9	NMOD	-1
11	mitochondrial-dependent	mitochondrial-dependent	B-NP	JJ	O	12	NMOD	-1
12	apoptosis	apoptosis	I-NP	NN	O	10	PMOD	0
13	with	with	B-PP	IN	O	9	NMOD	-1
14	release	release	B-NP	NN	O	19	NMOD	14	release
15	of	of	B-PP	IN	O	14	NMOD	-1
16	cytochrome	cytochrome	B-NP	NN	B-protein	17	NMOD	-1
17	c	c	I-NP	NN	I-protein	15	PMOD	-1
18	and	and	I-NP	CC	O	19	NMOD	-1
19	loss	loss	I-NP	NN	O	13	PMOD	0
20	of	of	B-PP	IN	O	19	NMOD	-1
21	mitochondrial	mitochondrial	B-NP	JJ	O	23	NMOD	-1
22	transmembrane	transmembrane	I-NP	JJ	O	23	NMOD	-1
23	potential	potential	I-NP	NN	O	20	PMOD	0
24	and	and	O	CC	O	7	VMOD	-1
25	was	be	B-VP	VBD	O	7	VMOD	-1
26	suppressed	suppress	I-VP	VBN	O	25	VC	0
27	in	in	B-PP	IN	O	26	VMOD	-1
28	Apaf-1	Apaf-1	B-NP	NN	B-protein	34	NMOD	-1
29	or	or	I-NP	CC	O	34	NMOD	-1
30	caspase-9	caspase-9	I-NP	NN	B-cell_line	34	NMOD	-1
31	knockout	knockout	I-NP	NN	I-cell_line	34	NMOD	19	knockout
32	mouse	mouse	I-NP	NN	I-cell_line	34	NMOD	-1
33	embryonic	embryonic	I-NP	JJ	I-cell_line	34	NMOD	-1
34	fibroblasts	fibroblast	I-NP	NNS	I-cell_line	27	PMOD	-1
35	.	.	O	.	O	7	P	-1

1	When	When	B-ADVP	WRB	O	10	VMOD	-1
2	injected	inject	B-VP	VBN	O	1	SBAR	19	injected
3	in	in	B-PP	IN	O	2	VMOD	-1
4	human	human	B-NP	JJ	O	7	NMOD	-1
5	breast	breast	I-NP	NN	O	7	NMOD	-1
6	cancer	cancer	I-NP	NN	O	7	NMOD	-1
7	xenografts	xenograft	I-NP	NNS	O	3	PMOD	-1
8	,	,	O	,	O	10	P	-1
9	pAd-T34A	pAd-T34A	B-NP	NN	B-protein	10	SUB	-1
10	inhibited	inhibit	B-VP	VBD	O	0	ROOT	18	inhibited
11	growth	growth	B-NP	NN	O	10	OBJ	4	growth
12	of	of	B-PP	IN	O	11	NMOD	-1
13	established	establish	B-NP	VBN	O	14	NMOD	0
14	tumors	tumor	I-NP	NNS	O	12	PMOD	-1
15	and	and	O	CC	O	10	VMOD	-1
16	triggered	trigger	B-VP	VBD	O	10	VMOD	17	triggered
17	tumor	tumor	B-NP	NN	O	19	NMOD	-1
18	cell	cell	I-NP	NN	O	19	NMOD	-1
19	apoptosis	apoptosis	I-NP	NN	O	16	OBJ	5	apoptosis
20	in	in	B-ADVP	FW	O	10	VMOD	-1
21	vivo	vivo	I-ADVP	FW	O	20	AMOD	-1
22	.	.	O	.	O	10	P	-1

1	This	This	B-NP	DT	O	2	SUB	-1
2	was	be	B-VP	VBD	O	0	ROOT	-1
3	associated	associate	I-VP	VBN	O	2	VC	0
4	with	with	B-PP	IN	O	3	VMOD	-1
5	a	a	B-NP	DT	O	9	NMOD	-1
6	approximately	approximately	I-NP	RB	O	9	NMOD	-1
7	60	60	I-NP	CD	O	6	AMOD	-1
8	%	%	I-NP	NN	O	6	AMOD	-1
9	reduction	reduction	I-NP	NN	O	4	PMOD	18	reduction
10	in	in	B-PP	IN	O	9	NMOD	-1
11	tumor-derived	tumor-derived	B-NP	JJ	B-cell_type	13	NMOD	-1
12	blood	blood	I-NP	NN	I-cell_type	13	NMOD	-1
13	vessels	vessel	I-NP	NNS	I-cell_type	10	PMOD	-1
14	by	by	B-PP	IN	O	9	NMOD	-1
15	quantitative	quantitative	B-NP	JJ	O	16	NMOD	-1
16	morphometry	morphometry	I-NP	NN	O	14	PMOD	-1
17	of	of	B-PP	IN	O	16	NMOD	-1
18	CD31-stained	CD31-stained	B-NP	JJ	B-protein	20	NMOD	-1
19	tumor	tumor	I-NP	NN	I-protein	20	NMOD	-1
20	areas	area	I-NP	NNS	I-protein	17	PMOD	-1
21	,	,	O	,	O	23	P	-1
22	and	and	O	CC	O	23	NMOD	-1
23	appearance	appearance	B-NP	NN	O	2	VMOD	0
24	of	of	B-PP	IN	O	23	NMOD	-1
25	endothelial	endothelial	B-NP	JJ	B-cell_type	27	NMOD	-1
26	cell	cell	I-NP	NN	I-cell_type	27	NMOD	-1
27	apoptosis	apoptosis	I-NP	NN	O	24	PMOD	5	apoptosis
28	by	by	B-PP	IN	O	23	NMOD	-1
29	internucleosomal	internucleosomal	B-NP	JJ	O	31	NMOD	-1
30	DNA	DNA	I-NP	NN	O	31	NMOD	-1
31	fragmentation	fragmentation	I-NP	NN	O	28	PMOD	-1
32	in	in	B-ADVP	FW	O	23	NMOD	-1
33	vivo	vivo	I-ADVP	FW	O	32	AMOD	-1
34	.	.	O	.	O	2	P	-1

1	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	Survivin	Survivin	B-NP	NN	O	4	SUB	-1
4	functions	function	B-VP	VBZ	O	20	VMOD	0
5	as	as	B-PP	IN	O	4	VMOD	-1
6	a	a	B-NP	DT	O	9	NMOD	-1
7	novel	novel	I-NP	JJ	O	8	AMOD	-1
8	upstream	upstream	I-NP	JJ	O	9	NMOD	-1
9	regulator	regulator	I-NP	NN	O	5	PMOD	0
10	of	of	B-PP	IN	O	9	NMOD	-1
11	mitochondrial-dependent	mitochondrial-dependent	B-NP	JJ	O	12	NMOD	-1
12	apoptosis	apoptosis	I-NP	NN	O	10	PMOD	0
13	,	,	O	,	O	20	P	-1
14	and	and	O	CC	O	20	VMOD	-1
15	molecular	molecular	B-NP	JJ	O	16	NMOD	-1
16	targeting	targeting	I-NP	NN	O	20	SUB	0
17	of	of	B-PP	IN	O	16	NMOD	-1
18	this	this	B-NP	DT	O	19	NMOD	-1
19	pathway	pathway	I-NP	NN	O	17	PMOD	0
20	results	result	B-VP	VBZ	O	1	NMOD	0
21	in	in	B-PP	IN	O	20	VMOD	-1
22	anticancer	anticancer	B-NP	JJ	O	23	NMOD	-1
23	activity	activity	I-NP	NN	O	21	PMOD	0
24	via	via	B-PP	IN	O	23	NMOD	0
25	a	a	B-NP	DT	O	27	NMOD	-1
26	dual	dual	I-NP	JJ	O	27	NMOD	-1
27	mechanism	mechanism	I-NP	NN	O	35	NMOD	0
28	of	of	B-PP	IN	O	27	NMOD	-1
29	induction	induction	B-NP	NN	O	28	PMOD	17	induction
30	of	of	B-PP	IN	O	29	NMOD	-1
31	tumor	tumor	B-NP	NN	O	33	NMOD	-1
32	cell	cell	I-NP	NN	O	33	NMOD	-1
33	apoptosis	apoptosis	I-NP	NN	O	30	PMOD	5	apoptosis
34	and	and	O	CC	O	35	NMOD	-1
35	suppression	suppression	B-NP	NN	O	24	PMOD	18	suppression
36	of	of	B-PP	IN	O	35	NMOD	-1
37	angiogenesis	angiogenesis	B-NP	NN	O	36	PMOD	3	angiogenesis
38	.	.	O	.	O	1	P	-1

